Menu
Sign In Pricing Add Podcast
Podcast Image

The Oprah Podcast

Dr. Ania Jastreboff

14 Jan 2025

Description

In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy Kane who told her story of losing 160 pounds on weight loss medications last year on Oprah’s ABC Special: Shame, Blame and the Weight Loss Revolution. Also referenced in this episode: "The Let Them Theory: A Life-Changing Tool That Millions of People Can’t Stop Talking About" by Mel Robbins, published by Hay House LLC is available wherever books and audio books are sold. SUPPORT THE SHOW Subscribe: https://www.youtube.com/@Oprah Find Oprah’s Interview with Mel Robbins Here.   Follow Amy on Instagram Follow Amy on TikTok Follow Emma on TikTok Follow Emma on Instagram Follow Oprah Winfrey on Social: Instagram Facebook Learn more about your ad choices. Visit megaphone.fm/adchoices

Audio
Transcription

Full Episode

0.189 - 17.867 Advertisement Narrator

This episode of the Oprah podcast is brought to you by Booking.com. Listing your vacation rental on Booking.com opens the door to more guests. Booking.com is one of the most downloaded travel apps in the world that makes it the place to list your vacation rentals if you want to earn more with consistent bookings, reach new markets, and turn hosting into a steady income.

0

18.327 - 33.878 Advertisement Narrator

Over the past 25 years, they've helped more than 1.8 billion vacation rental guests find places to stay. So why not help them find yours? You can manage your bookings and have control over your property's calendar and finances. It's hosting on your terms. The best part? Getting started is super easy.

0

34.258 - 52.11 Advertisement Narrator

In less than 15 minutes, you can register your property and nearly half of partners get their first booking within a week. If you've already listed on another site, Booking.com makes it easy to import your property info and get going right away. Whether you're looking to earn that extra income or fill those vacant weekends, head over to booking.com to see how you can get started today.

0

52.53 - 59.337 Advertisement Narrator

The reach is global, the bookings are consistent, and the control is yours. For the bookings you've dreamed of, list your property on booking.com.

0

60.379 - 83.635 Oprah Winfrey

Whether you are listening on the Oprah podcast or watching on YouTube, I appreciate you being with us. Last year, millions tuned into my special on ABC, Shame, Blame, and the Weight Loss Revolution. It's now streaming on Hulu if you want to check it out. We're continuing the conversation around weight loss medications like Ozempic and Manjaro. People still don't understand it.

84.215 - 99.278 Oprah Winfrey

Is it the easy way out? It's absolutely the opposite. I'm joined on this podcast by Dr. Anya Yastribov, an endocrinologist and associate professor at the Yale School of Medicine. She has been studying GLP-1 medications for more than 20 years.

99.298 - 102.439 Dr. Ania Jastreboff

Obesity is not a choice. It is about biology.

102.679 - 117.106 Oprah Winfrey

We are diving into the latest research on these medications that roughly 15 million Americans are now using. Can you set the record straight on side effects? Dr. Anya is here to answer a lot of your common questions.

117.626 - 119.727 Listener Question

Is this something I could taper off of?

Comments

There are no comments yet.

Please log in to write the first comment.